Select Publications
Journal articles
, 2007, 'Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia', Human Molecular Genetics, 16, pp. 129 - 141
, 2007, 'Postnatal alterations in dopaminergic markers in the human prefrontal cortex', Neuroscience, 144, pp. 1109 - 1119
, 2007, 'Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain', Brain Research, 1139, pp. 95 - 109
, 2006, 'Synaptophysin protein and mRNA expression in the human hippocampal formation from birth to old age', Hippocampus, 16, pp. 645 - 654, http://dx.doi.org/10.1002/hipo.20194
, 2006, 'BDNF and trkB mRNA expression in the hippocampus and temporal cortex during the human lifespan', Gene Expression Patterns, 6, pp. 941 - 951, http://dx.doi.org/10.1016/j.modgep.2006.03.009
, 2006, 'Critical Factors in Gene Expression in Postmortem Human Brain: Focus on Studies in Schizophrenia', Biological Psychiatry, 60, pp. 650 - 658, http://dx.doi.org/10.1016/j.biopsych.2006.06.019
, 2006, 'Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5′ SNPs associated with the disease', Proceedings of the National Academy of Sciences of the United States of America, 103, pp. 6747 - 6752, http://dx.doi.org/10.1073/pnas.0602002103
, 2006, 'Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs', Human Molecular Genetics, 15, pp. 1245 - 1258, http://dx.doi.org/10.1093/hmg/ddl040
, 2006, 'Neuregulin 1 Transcripts Are Differentially Expressed in Schizophrenia and Regulated by 5′ SNPs Associated With the Disease', Focus, 4, pp. 350 - 359, http://dx.doi.org/10.1176/foc.4.3.350
, 2005, 'Alteration in estrogen receptor α mRNA levels in frontal cortex and hippocampus of patients with major mental illness', Biological Psychiatry, 58, pp. 812 - 824, http://dx.doi.org/10.1016/j.biopsych.2005.04.047
, 2005, 'A conserved mRNA expression profile of SREB2 (GPR85) in adult human, monkey, and rat forebrain', Molecular Brain Research, 138, pp. 58 - 69, http://dx.doi.org/10.1016/j.molbrainres.2005.04.002
, 2005, 'Expression of estrogen receptor alpha exon-deleted mRNA variants in the human and non-human primate frontal cortex', Neuroscience, 134, pp. 81 - 95, http://dx.doi.org/10.1016/j.neuroscience.2005.03.055
, 2005, 'Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia', Molecular Psychiatry, 10, pp. 637 - 650, http://dx.doi.org/10.1038/sj.mp.4001678
, 2005, 'Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia', Neuroscience, 133, pp. 453 - 461, http://dx.doi.org/10.1016/j.neuroscience.2005.02.037
, 2005, 'Discordant changes in cortical TrkC mRNA and protein during the human lifespan', European Journal of Neuroscience, 21, pp. 2433 - 2444, http://dx.doi.org/10.1111/j.1460-9568.2005.04074.x
, 2005, 'Basic fibroblast growth factor and fibroblast growth factor receptor-1 in the human hippocampal formation', Neuroscience, 131, pp. 219 - 233, http://dx.doi.org/10.1016/j.neuroscience.2004.09.070
, 2004, 'Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness', Biological Psychiatry, 56, pp. 844 - 852, http://dx.doi.org/10.1016/j.biopsych.2004.09.006
, 2004, 'Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia', Proceedings of the National Academy of Sciences of the United States of America, 101, pp. 12604 - 12609, http://dx.doi.org/10.1073/pnas.0405077101
, 2004, 'Neuregulin-1 (NRG-1) mRNA and protein in the adult human brain', Neuroscience, 127, pp. 125 - 136, http://dx.doi.org/10.1016/j.neuroscience.2004.04.026
, 2004, 'Postmortem investigations of the pathophysiology of schizophrenia: The role of susceptibility genes', Journal of Psychiatry and Neuroscience, 29, pp. 287 - 293
, 2004, 'Effects of chronic haloperidol and clozapine treatment on neurogenesis in the adult rat hippocampus', Neuropsychopharmacology, 29, pp. 1063 - 1069, http://dx.doi.org/10.1038/sj.npp.1300422
, 2004, 'Gene expression of metabolic enzymes and a protease inhibitor in the prefrontal cortex are decreased in schizophrenia', Neurochemical Research, 29, pp. 1245 - 1255, http://dx.doi.org/10.1023/B:NERE.0000023611.99452.47
, 2004, 'Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain', Archives of General Psychiatry, 61, pp. 544 - 555, http://dx.doi.org/10.1001/archpsyc.61.6.544
, 2004, 'Estradiol Alters Transcription Factor Gene Expression in Primate Prefrontal Cortex', Journal of Neuroscience Research, 76, pp. 306 - 314, http://dx.doi.org/10.1002/jnr.20076
, 2004, 'Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia', Molecular Psychiatry, 9, pp. 299 - 307, http://dx.doi.org/10.1038/sj.mp.4001434
, 2004, 'High-Level Expression of Dok-1 in Neurons of the Primate Prefrontal Cortex and Hippocampus', Journal of Neuroscience Research, 75, pp. 218 - 224, http://dx.doi.org/10.1002/jnr.10842
, 2004, 'Glutamate Carboxypeptidase II Gene Expression in the Human Frontal and Temporal Lobe in Schizophrenia', Neuropsychopharmacology, 29, pp. 117 - 125, http://dx.doi.org/10.1038/sj.npp.1300304
, 2004, 'Reduced spinophilin but not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia and mood disorders: Molecular evidence for a pathology of dendritic spines', American Journal of Psychiatry, 161, pp. 1848 - 1855, http://dx.doi.org/10.1176/ajp.161.10.1848
, 2004, 'Postmortem investigations of the pathophysiology of schizophrenia: the role of susceptibility genes', Journal of Psychiatry and Neuroscience, 29, pp. 287 - 293, http://dx.doi.org/10.1139/jpn.0430
, 2004, 'Reduced GSK-alpha mRNA levels in postmortem dorsolateral prefrontal cortex of schizophrenic patients.', Journal of Neural Transmission, 111, pp. 1583 - 1592, http://dx.doi.org/10.1007/s00702-004-0166-3
, 2003, 'Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development', Molecular Psychiatry, 8, pp. 797 - 810, http://dx.doi.org/10.1038/sj.mp.4001319
, 2003, 'Expression of NMDA receptor NR1, NR2A and NR2B subunit mRNAs during development of the human hippocampal formation', European Journal of Neuroscience, 18, pp. 1197 - 1205, http://dx.doi.org/10.1046/j.1460-9568.2003.02850.x
, 2003, 'Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia', Molecular Psychiatry, 8, pp. 592 - 610, http://dx.doi.org/10.1038/sj.mp.4001308
, 2003, 'Catechol O-methyltransferase (COMT) mRNA expression in the dorsolateral prefrontal cortex of patients with schizophrenia', Neuropsychopharmacology, 28, pp. 1521 - 1530, http://dx.doi.org/10.1038/sj.npp.1300218
, 2003, 'Catechol O-methyltransferase mRNA expression in human and rat brain: Evidence for a role in cortical neuronal function', Neuroscience, 116, pp. 127 - 137, http://dx.doi.org/10.1016/S0306-4522(02)00556-0
, 2003, 'Epidermal growth factor receptor expression is related to post-mitotic events in cerebellar development: Regulation by thyroid hormone', Developmental Brain Research, 140, pp. 1 - 13, http://dx.doi.org/10.1016/S0165-3806(02)00539-4
, 2003, 'Changes in NMDA Receptor Subunit mRNAs and Cyclophilin mRNA during Development of the Human Hippocampus', Annals of the New York Academy of Sciences, 1003, pp. 426 - 430, http://dx.doi.org/10.1196/annals.1300.043
, 2003, 'Gene expression in dopamine and GABA systems in an animal model of schizophrenia: Effects of antipsychotic drugs', European Journal of Neuroscience, 18, pp. 391 - 402, http://dx.doi.org/10.1046/j.1460-9568.2003.02738.x
, 2002, 'Alterations in trkB mRNA in the human prefrontal cortex throughout the lifespan', European Journal of Neuroscience, 15, pp. 269 - 280, http://dx.doi.org/10.1046/j.0953-816x.2001.01858.x
, 2002, 'BDNF mRNA expression during postnatal development, maturation and aging of the human prefrontal cortex', Developmental Brain Research, 139, pp. 139 - 150, http://dx.doi.org/10.1016/S0165-3806(02)00540-0
, 2002, 'Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders', Molecular Psychiatry, 7, pp. 985 - 994, http://dx.doi.org/10.1038/sj.mp.4001139
, 2001, 'Synaptophysin and GAP-43 mRNA levels in the hippocampus of subjects with schizophrenia', Schizophrenia Research, 49, pp. 89 - 98, http://dx.doi.org/10.1016/S0920-9964(00)00052-9
, 2001, 'Delayed onset of enhanced MK-801-induced motor hyperactivity after neonatal lesions of the rat ventral hippocampus', Biological Psychiatry, 49, pp. 528 - 539, http://dx.doi.org/10.1016/S0006-3223(00)00968-9
, 2001, 'BDNF mRNA expression in rat hippocampus and prefrontal cortex: Effects of neonatal ventral hippocampal damage and antipsychotic drugs', European Journal of Neuroscience, 14, pp. 135 - 144, http://dx.doi.org/10.1046/j.1460-9568.2001.01633.x
, 2001, 'Reduced GAP-43 mRNA in dorsolateral prefrontal cortex of patients with schizophrenia', Cerebral Cortex, 11, pp. 136 - 147, http://dx.doi.org/10.1093/cercor/11.2.136
, 2000, 'Differential DNA damage in response to the neonatal and adult excitotoxic hippocampal lesion in rats', European Journal of Neuroscience, 12, pp. 4424 - 4433, http://dx.doi.org/10.1046/j.0953-816X.2000.01320.x
, 2000, 'Localization of epidermal growth factor receptors and putative neuoblasts in human subependymal zone', Journal of Comparative Neurology, 423, pp. 359 - 372, http://dx.doi.org/10.1002/1096-9861(20000731)423:3<359::AID-CNE1>3.0.CO;2-0
, 1999, 'The weaver GIRK2 mutation leads to decreased levels of serum thyroid hormone: Characterization of the effect on midbrain dopaminergic neuron survival', Experimental Neurology, 160, pp. 413 - 424, http://dx.doi.org/10.1006/exnr.1999.7231
, 1998, 'A candidate molecule approach to defining developmental pathology in schizophrenia', Schizophrenia Bulletin, 24, pp. 303 - 316, http://dx.doi.org/10.1093/oxfordjournals.schbul.a033327
, 1998, 'The neuroanatomy and neurochemistry of schizophrenia', Psychiatric Clinics of North America, 21, pp. 57 - 75, http://dx.doi.org/10.1016/S0193-953X(05)70361-0